Stay updated on Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:04:11.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:52:04.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:52:34.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page has been updated to reflect new information regarding the evaluation of TAK-981 in combination with cetuximab and avelumab for head and neck cancer, including the addition of collaborators and a revision update. The previous detailed description of the study's methodology has been removed.
    Difference
    34%
    Check dated 2025-04-16T01:58:15.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T21:30:39.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:22:01.000Z thumbnail image

Stay in the know with updates to Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.